These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9132654)

  • 21. Goodpasture's syndrome in a patient receiving penicillamine and carbimazole.
    Peces R; Riera JR; Arboleya LR; López-Larrea C; Alvarez J
    Nephron; 1987; 45(4):316-20. PubMed ID: 3587472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotic syndrome in the course of treatment of Wilson's disease with DL-penicillamine.
    Karp M; Lurie M; Yonis Z
    Arch Dis Child; 1966 Dec; 41(220):684-7. PubMed ID: 5927925
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunopathologic studies in glomerular diseases with membranous lesions.
    Murphy WM; Deodhar SD; McCormack LJ; Osborne DG
    Am J Clin Pathol; 1973 Sep; 60(3):364-76. PubMed ID: 4580510
    [No Abstract]   [Full Text] [Related]  

  • 24. [Penicillamine-induced glomerulonephritis].
    Koall W; Mampel E
    Z Urol Nephrol; 1977 Jan; 70(1):13-7. PubMed ID: 848141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multinucleated giant cells in antiglomerular basement membrane antibody-induced glomerulonephritis.
    Kalowski S; McKay DG; Howes EL; Csavossy I; Wolfson M
    Nephron; 1976; 16(6):415-26. PubMed ID: 1264313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nephrotic syndrome from the aspect of immunopathology--significance of degenerative membraneous thickening in the histological expression of glomerulonephritis].
    Fujimoto T
    Nihon Rinsho; 1968 May; 26(5):1064-71. PubMed ID: 4177874
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical significance of antiglomerular basement membrane antibody assay].
    Ohi H; Endoh M; Hatano M
    Nihon Rinsho; 1990 Feb; 48 Suppl():557-9. PubMed ID: 2192149
    [No Abstract]   [Full Text] [Related]  

  • 28. Nephrotic syndrome induced by D-penicillamine therapy.
    Jezersek P; Ferluga D
    Int Urol Nephrol; 1979; 11(4):349-61. PubMed ID: 536182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modern concepts of the immune pathogenesis of nephropathies].
    Belovezhdov N
    Vutr Boles; 1976; 15(1):1-10. PubMed ID: 131416
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proteinuria and nephrotic syndrome in penicillamine therapy. Reversibility of immunopathologic findings in animal experiments].
    Seelig HP; Seelig R
    Dtsch Med Wochenschr; 1977 Jul; 102(28):1035-6. PubMed ID: 891372
    [No Abstract]   [Full Text] [Related]  

  • 31. Relapse in anti glomerular basement membrane antibody mediated crescentic glomerulonephritis.
    Wu MJ; Moorthy AV; Beirne GJ
    Clin Nephrol; 1980 Feb; 13(2):97-102. PubMed ID: 7363520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serious side effects with D-penicillamine therapy for Wilson's disease].
    Storch W; Lössner J; Ruchholtz U
    Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):531-8. PubMed ID: 161403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental glomerulonephritis in the guinea pig. I. Glomerular lesions associated with antiglomerular basement membrane antibody deposits.
    Couser WG; Stilmant M; Lewis EJ
    Lab Invest; 1973 Aug; 29(2):236-43. PubMed ID: 4579664
    [No Abstract]   [Full Text] [Related]  

  • 34. [Various types of glomerulonephritis. Immune-complex induced glomerulonephritis].
    Sugisaki T
    Nihon Rinsho; 1988 Jun; 46(6):1316-21. PubMed ID: 3418900
    [No Abstract]   [Full Text] [Related]  

  • 35. Animal model of human disease: anti-glomerular-basement-membrane glomerulonephritis.
    Steblay RW
    Am J Pathol; 1979 Sep; 96(3):875-8. PubMed ID: 474722
    [No Abstract]   [Full Text] [Related]  

  • 36. The pathogenesis of glomerulonephritis.
    Dixon FJ
    Am J Med; 1968 Apr; 44(4):493-8. PubMed ID: 5642712
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma exchange in the successful treatment of drug-induced renal disease.
    Swainson CP; Thomson D; Short AI; Winney RJ
    Nephron; 1982; 30(3):244-9. PubMed ID: 7099337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Iatrogenic glomerulopathies].
    Lagrue G
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):439-43. PubMed ID: 4613872
    [No Abstract]   [Full Text] [Related]  

  • 39. Glomerulonephritis with coexistent immune deposits and antibasement membrane activity.
    Rajaraman S; Pinto JA; Cavallo T
    J Clin Pathol; 1984 Feb; 37(2):176-81. PubMed ID: 6363455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coincidence of myasthenia gravis and antiglomerular basement membrane glomerulonephritis: a combination of two antibody-mediated autoimmune diseases on day 15.
    Drube S; Maurin N; Sieberth HG
    Nephrol Dial Transplant; 1997 Jul; 12(7):1478-80. PubMed ID: 9249791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.